121 related articles for article (PubMed ID: 6379252)
1. [Carcinoma in situ of the urinary bladder: clinical experience and preliminary study of Thomsen-Friedenreich antigen].
Sasaki K; Maru A; Sakashita S; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1984 Feb; 75(2):269-77. PubMed ID: 6379252
[No Abstract] [Full Text] [Related]
2. [The study of Thomsen-Friedenreich antigen and prognosis of the patients with bladder tumor].
Kobayashi H; Obata K; Andou M
Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):674-9. PubMed ID: 3312742
[No Abstract] [Full Text] [Related]
3. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
Weinstein RS; Miller AW; Coon JS
Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
[No Abstract] [Full Text] [Related]
4. [The study on Thomsen-Friedenreich antigen in bladder tumor].
Oda Y
Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
[TBL] [Abstract][Full Text] [Related]
5. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
[No Abstract] [Full Text] [Related]
6. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
Sasaki K
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
[TBL] [Abstract][Full Text] [Related]
8. Multiple cell markers in bladder cancer. Principles and clinical applications.
Javadpour N
Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
[TBL] [Abstract][Full Text] [Related]
9. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of tumor specific antigens in bladder cancer using anti Thomsen-Friedenreich monoclonal antibody and soybean agglutinin].
Oda H; Oda T; Yokoyama M; Takeuchi M; Ohoka H; Utsumi S
Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):713-8. PubMed ID: 3226022
[No Abstract] [Full Text] [Related]
11. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
12. Thomsen-Friedenreich antigen in bladder cancer tissues detected by monoclonal antibody.
Yokoyama M; Ohoka H; Oda H; Oda T; Utsumi S; Takeuchi M
Hinyokika Kiyo; 1988 Feb; 34(2):255-8. PubMed ID: 3376817
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers in bladder cancer.
Huben RP
Urology; 1984 Mar; 23(3 Suppl):10-4. PubMed ID: 6367189
[No Abstract] [Full Text] [Related]
14. Thomsen-Friedenreich-related antigen in non-neoplastic ureter urothelium and transitional cell tumours of the urinary bladder. An immunohistochemical study employing the monoclonal antibody 49H.8.
Juhl BR; Hartzen SH; Hainau B
Acta Pathol Microbiol Immunol Scand A; 1987 Mar; 95(2):83-91. PubMed ID: 3551496
[TBL] [Abstract][Full Text] [Related]
15. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.
Ohoka H; Shinomiya H; Yokoyama M; Ochi K; Takeuchi M; Utsumi S
Urol Res; 1985; 13(2):47-50. PubMed ID: 4012935
[TBL] [Abstract][Full Text] [Related]
16. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
Kobayashi H
Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
[TBL] [Abstract][Full Text] [Related]
17. Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.
Coon JS; McCall A; Miller AW; Farrow GM; Weinstein RS
Cancer; 1985 Aug; 56(4):797-804. PubMed ID: 4016671
[TBL] [Abstract][Full Text] [Related]
18. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
Yamada T; Fukui I; Yokogawa M; Oshima H
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
[No Abstract] [Full Text] [Related]
19. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A.
Radzikowski CZ; Steuden I; Wiedlocha A; Kieler J; Tromholt V
Anticancer Res; 1989; 9(1):103-7. PubMed ID: 2650614
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody.
Oda H; Oda T; Ohoka H; Yokoyama M; Takeuchi M
Urol Res; 1990; 18(2):107-11. PubMed ID: 2339479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
